Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis

Anat Galor, Ron Margolis, Oswaldo M F Brasil, Victor L Perez Quinones, Peter K. Kaiser, Jonathan E. Sears, Careen Y. Lowder, Scott D. Smith

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Purpose: To evaluate the rates of adverse ocular events after intravitreal triamcinolone acetonide (IVTA) injection in patients with and without uveitis. Design: Retrospective observational case series. Participants: Two hundred twenty-two eyes of 173 patients were included in the study: 45 eyes of 31 patients with macular edema (ME) due to uveitis and 177 eyes of 142 patients with ME secondary to other etiologies. Methods: Retrospective review of patients who received IVTA at the Cole Eye Institute for ME attributable to various causes between the years 2001 and 2005. Data review of clinical records included patient demographics, etiology of ME, and adverse outcomes after injection. Rates of adverse outcomes in patients with and without uveitis were compared. Main Outcome Measures: Intraocular pressure (IOP) elevation and posterior subcapsular cataract (PSC) progression. Results: Uveitis patients were significantly younger, more likely to be female, and more likely to have had prior posterior sub-Tenon's capsule steroid injection and/or glaucoma therapy than their nonuveitis counterparts. In a multivariate analysis adjusting for the differences in these factors, the presence of uveitis was the strongest risk factor for an adverse IOP event (odds ratio, 2.5; 95% confidence interval [CI], 1.0-6.1; P = 0.05). The odds of having a documented increase in PSC after IVTA injection were 5.6 times greater in uveitis eyes (P = 0.007; 95% CI, 1.6-19.6). Conclusions: Intraocular pressure elevation and PSC progression occurred with greater frequency in uveitis patients receiving IVTA. Patients with uveitis treated with IVTA should be counseled about these risks and monitored closely.

Original languageEnglish
Pages (from-to)1912-1918
Number of pages7
JournalOphthalmology
Volume114
Issue number10
DOIs
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint

Triamcinolone
Uveitis
Triamcinolone Acetonide
Macular Edema
Intraocular Pressure
Cataract
Injections
Tenon Capsule
Confidence Intervals
Glaucoma
Multivariate Analysis
Odds Ratio
Steroids
Demography
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Galor, A., Margolis, R., Brasil, O. M. F., Perez Quinones, V. L., Kaiser, P. K., Sears, J. E., ... Smith, S. D. (2007). Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis. Ophthalmology, 114(10), 1912-1918. https://doi.org/10.1016/j.ophtha.2007.05.037

Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis. / Galor, Anat; Margolis, Ron; Brasil, Oswaldo M F; Perez Quinones, Victor L; Kaiser, Peter K.; Sears, Jonathan E.; Lowder, Careen Y.; Smith, Scott D.

In: Ophthalmology, Vol. 114, No. 10, 01.10.2007, p. 1912-1918.

Research output: Contribution to journalArticle

Galor, A, Margolis, R, Brasil, OMF, Perez Quinones, VL, Kaiser, PK, Sears, JE, Lowder, CY & Smith, SD 2007, 'Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis', Ophthalmology, vol. 114, no. 10, pp. 1912-1918. https://doi.org/10.1016/j.ophtha.2007.05.037
Galor A, Margolis R, Brasil OMF, Perez Quinones VL, Kaiser PK, Sears JE et al. Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis. Ophthalmology. 2007 Oct 1;114(10):1912-1918. https://doi.org/10.1016/j.ophtha.2007.05.037
Galor, Anat ; Margolis, Ron ; Brasil, Oswaldo M F ; Perez Quinones, Victor L ; Kaiser, Peter K. ; Sears, Jonathan E. ; Lowder, Careen Y. ; Smith, Scott D. / Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis. In: Ophthalmology. 2007 ; Vol. 114, No. 10. pp. 1912-1918.
@article{659d957ec3ea4f958158d9716a20c15d,
title = "Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis",
abstract = "Purpose: To evaluate the rates of adverse ocular events after intravitreal triamcinolone acetonide (IVTA) injection in patients with and without uveitis. Design: Retrospective observational case series. Participants: Two hundred twenty-two eyes of 173 patients were included in the study: 45 eyes of 31 patients with macular edema (ME) due to uveitis and 177 eyes of 142 patients with ME secondary to other etiologies. Methods: Retrospective review of patients who received IVTA at the Cole Eye Institute for ME attributable to various causes between the years 2001 and 2005. Data review of clinical records included patient demographics, etiology of ME, and adverse outcomes after injection. Rates of adverse outcomes in patients with and without uveitis were compared. Main Outcome Measures: Intraocular pressure (IOP) elevation and posterior subcapsular cataract (PSC) progression. Results: Uveitis patients were significantly younger, more likely to be female, and more likely to have had prior posterior sub-Tenon's capsule steroid injection and/or glaucoma therapy than their nonuveitis counterparts. In a multivariate analysis adjusting for the differences in these factors, the presence of uveitis was the strongest risk factor for an adverse IOP event (odds ratio, 2.5; 95{\%} confidence interval [CI], 1.0-6.1; P = 0.05). The odds of having a documented increase in PSC after IVTA injection were 5.6 times greater in uveitis eyes (P = 0.007; 95{\%} CI, 1.6-19.6). Conclusions: Intraocular pressure elevation and PSC progression occurred with greater frequency in uveitis patients receiving IVTA. Patients with uveitis treated with IVTA should be counseled about these risks and monitored closely.",
author = "Anat Galor and Ron Margolis and Brasil, {Oswaldo M F} and {Perez Quinones}, {Victor L} and Kaiser, {Peter K.} and Sears, {Jonathan E.} and Lowder, {Careen Y.} and Smith, {Scott D.}",
year = "2007",
month = "10",
day = "1",
doi = "10.1016/j.ophtha.2007.05.037",
language = "English",
volume = "114",
pages = "1912--1918",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Adverse Events after Intravitreal Triamcinolone in Patients with and without Uveitis

AU - Galor, Anat

AU - Margolis, Ron

AU - Brasil, Oswaldo M F

AU - Perez Quinones, Victor L

AU - Kaiser, Peter K.

AU - Sears, Jonathan E.

AU - Lowder, Careen Y.

AU - Smith, Scott D.

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Purpose: To evaluate the rates of adverse ocular events after intravitreal triamcinolone acetonide (IVTA) injection in patients with and without uveitis. Design: Retrospective observational case series. Participants: Two hundred twenty-two eyes of 173 patients were included in the study: 45 eyes of 31 patients with macular edema (ME) due to uveitis and 177 eyes of 142 patients with ME secondary to other etiologies. Methods: Retrospective review of patients who received IVTA at the Cole Eye Institute for ME attributable to various causes between the years 2001 and 2005. Data review of clinical records included patient demographics, etiology of ME, and adverse outcomes after injection. Rates of adverse outcomes in patients with and without uveitis were compared. Main Outcome Measures: Intraocular pressure (IOP) elevation and posterior subcapsular cataract (PSC) progression. Results: Uveitis patients were significantly younger, more likely to be female, and more likely to have had prior posterior sub-Tenon's capsule steroid injection and/or glaucoma therapy than their nonuveitis counterparts. In a multivariate analysis adjusting for the differences in these factors, the presence of uveitis was the strongest risk factor for an adverse IOP event (odds ratio, 2.5; 95% confidence interval [CI], 1.0-6.1; P = 0.05). The odds of having a documented increase in PSC after IVTA injection were 5.6 times greater in uveitis eyes (P = 0.007; 95% CI, 1.6-19.6). Conclusions: Intraocular pressure elevation and PSC progression occurred with greater frequency in uveitis patients receiving IVTA. Patients with uveitis treated with IVTA should be counseled about these risks and monitored closely.

AB - Purpose: To evaluate the rates of adverse ocular events after intravitreal triamcinolone acetonide (IVTA) injection in patients with and without uveitis. Design: Retrospective observational case series. Participants: Two hundred twenty-two eyes of 173 patients were included in the study: 45 eyes of 31 patients with macular edema (ME) due to uveitis and 177 eyes of 142 patients with ME secondary to other etiologies. Methods: Retrospective review of patients who received IVTA at the Cole Eye Institute for ME attributable to various causes between the years 2001 and 2005. Data review of clinical records included patient demographics, etiology of ME, and adverse outcomes after injection. Rates of adverse outcomes in patients with and without uveitis were compared. Main Outcome Measures: Intraocular pressure (IOP) elevation and posterior subcapsular cataract (PSC) progression. Results: Uveitis patients were significantly younger, more likely to be female, and more likely to have had prior posterior sub-Tenon's capsule steroid injection and/or glaucoma therapy than their nonuveitis counterparts. In a multivariate analysis adjusting for the differences in these factors, the presence of uveitis was the strongest risk factor for an adverse IOP event (odds ratio, 2.5; 95% confidence interval [CI], 1.0-6.1; P = 0.05). The odds of having a documented increase in PSC after IVTA injection were 5.6 times greater in uveitis eyes (P = 0.007; 95% CI, 1.6-19.6). Conclusions: Intraocular pressure elevation and PSC progression occurred with greater frequency in uveitis patients receiving IVTA. Patients with uveitis treated with IVTA should be counseled about these risks and monitored closely.

UR - http://www.scopus.com/inward/record.url?scp=34748838037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748838037&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2007.05.037

DO - 10.1016/j.ophtha.2007.05.037

M3 - Article

C2 - 17908594

AN - SCOPUS:34748838037

VL - 114

SP - 1912

EP - 1918

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 10

ER -